Navigation Links
Medipacs Chosen to Present at Invest Southwest Capital Conference
Date:11/19/2008

TUCSON, Ariz., Nov. 19 /PRNewswire/ -- Medipacs, Inc., a Tucson based drug delivery device company announces today the company has been selected to present at the Invest Southwest Capital Conference to be held in Scottsdale, AZ on December 10 and 11, 2008.

One of only 12 companies to present at the conference, Medipacs was selected from 84 submissions in a variety of high-tech fields. "Generally speaking, (the businesses) have to be highly scalable and highly defensible" said Dave Bittner, this year's conference chairman.

Medipacs was founded in 2004 by Mark Banister, a career entrepreneur and was awarded several grants from the National Science Foundation and Science Foundation of Arizona which helped advance fundamentally new polymer science to the point of attracting investor attention. Medipacs' novel polymer gel expands to multiples of its original size. This large expansion ratio occurs precisely and rapidly which enables a variety of practical, low cost drug delivery devices to be used for administering small volume Parenteral (SVP) drugs. According to recent studies, SVP drugs are often implicated in drug delivery errors that extend hospital stays and increase variable costs and Medipacs devices are aimed at reducing many of these errors with its novel delivery systems.

Since June 2007, the company has raised $1.7M from Mesa Verde Ventures, a seed stage venture firm specializing in medical device start-ups in San Diego, CA, and from angel investors in Tucson, San Diego and Washington DC. Mark McWilliams, CEO of Medipacs, has been the co-founder of two drug delivery device companies which brought new drug delivery technologies to market. He has also developed devices and systems serving other medical fields.

Bill Bloom, V.P. Engineering, a Caltech graduate that has worked in the medical device field for over 35 years and who developed insulin pumps for Alfred Mann at Mini-Med in the 1980's and then at Siemens leads the engineering effort and said: "Medipacs has developed the first truly unique infusion pump mechanism I have seen in the last 30 years and it is the most versatile, low cost mechanism for accurately metering drugs which I have ever seen or been part of commercializing. Medipacs' technology can disrupt and obsolete existing methods for delivery of SVP drugs."

About Medipacs

Medipacs, Inc. is a Tucson based drug delivery device company with expertise in hydro gel polymers. It is developing advanced infusion technologies and is now focused on its first commercial application, a programmable disposable infusion device called a Mini-Infuser(TM). The company is located at the Arizona Center for Innovation. Please contact: Mark McWilliams 858-227-0569 MarkMcWilliams@mediapcs.com

About the Invest Southwest Capital Conference

Invest Southwest has been connecting entrepreneurs and investors in Arizona and the Southwest for over 15 years. Companies that have presented at past Invest Southwest conferences include Ventana Medical, Flypaper, NetPro, Vivid Semiconductor, and AutoXray. Companies submitting to present seek between $250,000 and $5MM in capital. For more information about the conference, with title sponsor The Miller Group, visit http://www.investsouthwest.org.


'/>"/>
SOURCE Medipacs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medipacs Appoints Advisory Board Members
2. Medipacs Initial Financing
3. Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program
4. EDS Chosen to Manage Combat Veteran Call Center for Department of Veterans Affairs
5. The Initiative for Elder Planning Studies Has Chosen to Include The Estate Vault as Part of Their Membership Offering
6. Syndicoms Collaborative Web Platform Chosen to Facilitate Clinical Trials for Lumbar Disc Device from Aesculap Implant Systems
7. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
8. Local Families Chosen for Ambassador Role for 2008 March for Babies
9. Ten Finalists Chosen for 2007 Hutch Award
10. Vanderbilt Medical Center chosen as Evidence-based Practice Center
11. WaveMark, Inc. is Chosen by UMass Memorial Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... (NYLF): Medicine will have the unique opportunity to get hands-on experience in ... high school students an immersive experience to gain invaluable, real-life medical skills that ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand ... at the Icahn School of Medicine at Mount Sinai has found. The study ... young children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite ...
(Date:12/7/2016)... ... December 07, 2016 , ... OC87 Recovery Diaries (oc87recoverydiaries.com) recounts ... in a unique, personal perspective through animation. , That woman is Sheri ... at her private psychotherapy practice. Sheri’s mother, Pearl, lived with schizophrenia. , ...
(Date:12/7/2016)... , ... December 07, 2016 , ... It is vital ... is with useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, ... 'need for speed' and the need to operate in a GLP (Good Laboratory Practice) ...
(Date:12/7/2016)... ... 07, 2016 , ... Levels of a protein in the blood associated with ... online in the journal Radiology. , Heart disease and brain disease exact a major ... rapidly aging population. Damage to both organs often occurs at a subclinical stage, or ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Bodycad announced it has been ... accuracy, reproducibility and speed for 3D constructs via ... bone orthopaedic applications. These patents are critical to ... restorations based on each patient,s distinct anatomy. ... harnesses the world,s first suite of orthopaedic CAD/CAM ...
(Date:12/8/2016)... 2016  Pennsylvania Physician General Dr. Rachel ... Programs Gary Tennis released safe prescribing ... benzodiazepines, developed with the help of a task ... are frequently prescribed for anxiety or insomnia," said ... opioid pain medications, benzodiazepines pose a significant risk ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: